Related Experiment Video
Updated: Jun 26, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation
Samira B Jeimy1, Nola Fuller, Subia Tasneem
1Department of Pathology and Molecular Medicine, Health Sciences Center, McMaster University, 1200 Main St. West, Hamilton, Ontario, Canada, L8N 3Z5.
Abstract:
Multimerin 1 (MMRN1) is a polymeric, factor V (FV) binding protein that is stored in platelet and endothelial cell secretion granules but is undetectable in normal plasma. In human platelet alpha-granules, FV is stored complexed to MMRN1, predominantly by noncovalent binding interactions. The FV binding site for MMRN1 is located in the light chain, where it overlaps the C1 and C2 domain membrane binding sites essential for activated FV (FVa) procoagulant function. Surface plasmon resonance (SPR), circular dichroism (CD) and thrombin generation assays were used to study the binding of FV and FVa to MMRN1, and the functional consequences. FV and FVa bound MMRN1 with high affinities (K(D): 2 and 7 nM, respectively). FV dissociated more slowly from MMRN1 than FVa in SPR experiments, and CD analyses suggested greater conformational changes in mixtures of FV and MMRN1 than in mixtures of FVa and MMRN1. SPR analyses indicated that soluble phosphatidylserine (1,2-Dicaproylsn-glycero-3-phospho-L-serine) competitively inhibited both FV-MMRN1 and FVa-MMRN1 binding. Furthermore, exogenous MMRN1 delayed and reduced thrombin generation by plasma and platelets, and it reduced thrombin generation by preformed FVa. Exogenous MMRN1 also delayed FV activation, triggered by adding tissue factor to plasma, or by adding purified thrombin or factor Xa to purified FV. The high affinity binding of FV to MMRN1 may facilitate the costorage of the two proteins in platelet alpha-granules. As a consequence, MMRN1 release during platelet activation may limit platelet dependent thrombin generation in vivo.
Insights
Multimerin 1 (MMRN1) binds factor V (FV) and its activated form (FVa) with high affinity. Exogenous MMRN1 inhibits thrombin generation, suggesting a role in regulating blood coagulation.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Multimerin 1 (MMRN1) is a protein found in platelet and endothelial cell granules.
- It forms complexes with factor V (FV) within human platelet alpha-granules.
- The FV binding site on MMRN1 overlaps with membrane binding sites crucial for activated FV (FVa) function.
Purpose of the Study:
- To investigate the binding kinetics and functional consequences of factor V (FV) and activated factor V (FVa) interaction with Multimerin 1 (MMRN1).
- To elucidate the role of MMRN1 in regulating thrombin generation and FV activation.
Main Methods:
- Surface Plasmon Resonance (SPR) to measure binding affinities and kinetics.
- Circular Dichroism (CD) spectroscopy to assess conformational changes.
- Thrombin generation assays using plasma, platelets, and purified proteins.
Main Results:
- FV and FVa exhibit high-affinity binding to MMRN1 (K(D) of 2 nM and 7 nM, respectively).
- Soluble phosphatidylserine competitively inhibits FV-MMRN1 and FVa-MMRN1 binding.
- Exogenous MMRN1 delays and reduces thrombin generation and inhibits FV activation.
Conclusions:
- High-affinity binding of FV to MMRN1 facilitates their co-storage in platelet alpha-granules.
- MMRN1 release upon platelet activation may limit platelet-dependent thrombin generation in vivo.
- MMRN1 plays a regulatory role in the coagulation cascade.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Intracellular Signaling Affects Focal Adhesions
Some...

